West Pharmaceutical Services (WST) Short-term Investments (2011 - 2013)

West Pharmaceutical Services has disclosed Short-term Investments across 3 years of filings, most recently posting $7.5 million for Q4 2013.

• Short-term Investments for Q4 2013 came in at $7.5 million, down 39.52% year-over-year; the trailing twelve-month figure through Dec 2013 was $7.5 million (down 39.52% YoY), and the FY2013 annual result was $7.5 million, down 39.52% from the prior year.
• Short-term Investments came in at $7.5 million for Q4 2013 at West Pharmaceutical Services, roughly flat from $7.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $26.5 million in Q4 2011 to a low of $7.5 million in Q2 2013.
• The 3-year median for Short-term Investments is $10.3 million (2012), against an average of $14.6 million.
• Peak annual rise in Short-term Investments reached 39.52% in 2013, while the deepest fall reached 70.59% in 2013.
• West Pharmaceutical Services' Short-term Investments stood at $26.5 million in 2011, then plunged by 53.21% to $12.4 million in 2012, then sank by 39.52% to $7.5 million in 2013.
• The last three Short-term Investments figures came in at $7.5 million (Q4 2013), $7.5 million (Q3 2013), and $7.5 million (Q2 2013), per Business Quant data.